Related references
Note: Only part of the references are listed.Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum
Andrea Riccardo Filippi et al.
RADIATION ONCOLOGY (2020)
The dose–response characteristics of four NTCP models: using a novel CT-based radiomic method to quantify radiation-induced lung density changes
Dustin Begosh-Mayne et al.
Scientific Reports (2020)
The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)
N. George Mikhaeel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study
Jorne Lionel Biccler et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal Lymphoma
Ashlyn S. Everett et al.
PRACTICAL RADIATION ONCOLOGY (2019)
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Michael Fuchs et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients
Mario Levis et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Normal tissue complication probability (NTCP) models for modern radiation therapy
Giuseppe Palma et al.
SEMINARS IN ONCOLOGY (2019)
Proton Therapy For Lymphomas: Current State Of The Art
Umberto Ricardi et al.
ONCOTARGETS AND THERAPY (2019)
Comparative treatment planning study for mediastinal Hodgkin's lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy
Anneli Edvardsson et al.
ACTA ONCOLOGICA (2019)
Deep-Inspiration Breath-Hold Intensity Modulated Radiation Therapy to the Mediastinum for Lymphoma Patients: Setup Uncertainties and Margins
Michalis Aristophanous et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy
Chelsea C. Pinnix et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Intensity Modulated Radiation Therapy and Second Cancer Risk in Adults
Andrea Riccardo Filippi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
A study of the dosimetric characteristics between different fixed-field IMRT and VMAT in early-stage primary mediastinal B-cell lymphoma
Li-Ming Xu et al.
MEDICAL DOSIMETRY (2018)
Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines
Bouthaina Shbib Dabaja et al.
BLOOD (2018)
Comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma
Alison Starke et al.
RADIOTHERAPY AND ONCOLOGY (2018)
A Prospective, Observational Study Evaluating Early Subclinical Cardiotoxicity with Global Longitudinal Strain Imaging in Lymphoma Patients Treated with Chemotherapy plus /- Mediastinal Radiation Therapy: The CARDIOCARE Project
M. Levis et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction
Ezra Hahn et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial
Marc P. E. Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials
Carolyn Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials
Stephanie Sasse et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Risk of secondary cancers: Bridging epidemiology and modeling
Uwe Schneider et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2017)
A cardiac contouring atlas for radiotherapy
Frances Duane et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy
Andrea Riccardo Filippi et al.
CURRENT ONCOLOGY REPORTS (2017)
Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines
Frederika A. van Nimwegen et al.
BLOOD (2017)
Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literature
Nadia Besson et al.
BRITISH JOURNAL OF RADIOLOGY (2016)
Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy
S. Horn et al.
CANCER RADIOTHERAPIE (2016)
Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma
Frederika A. van Nimwegen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Mammography and MRI for screening women who underwent chest radiation therapy (lymphoma survivors): recommendations for surveillance from the Italian College of Breast Radiologists by SIRM
Giovanna Mariscotti et al.
RADIOLOGIA MEDICA (2016)
Volumetric-modulated arc therapy (VMAT) versus 3D-conformal radiation therapy in supra-diaphragmatic Hodgkin's Lymphoma with mediastinal involvement: A dosimetric comparison
Christine Higby et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2016)
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy
Gabriele Simontacchi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Predictors of Radiation Pneumonitis in Patients Receiving Intensity Modulated Radiation Therapy for Hodgkin and Non-Hodgkin Lymphoma
Chelsea C. Pinnix et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Optimized Volumetric Modulated Arc Therapy Versus 3D-CRT for Early Stage Mediastinal Hodgkin Lymphoma Without Axillary Involvement: A Comparison of Second Cancers and Heart Disease Risk
Andrea Riccardo Filippi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Minimizing Late Effects for Patients With Mediastinal Hodgkin Lymphoma: Deep Inspiration Breath-Hold, IMRT, or Both?
Marianne C. Aznar et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
David J. Cutter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin's Lymphoma
John Radford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma
Michael Schaapveld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Modeling the risk of radiation-induced lung fibrosis: Irradiated heart tissue is as important as irradiated lung
Laura Cella et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Breath-hold technique in conventional APPA or intensity-modulated radiotherapy for Hodgkin's lymphoma
Jan Kriz et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2015)
The Role of Radiotherapy in Hodgkin's Lymphoma: What Has Been Achieved during the Last 50 Years?
Magdalena Witkowska et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Cardiovascular Disease After Hodgkin Lymphoma Treatment 40-Year Disease Risk
Frederika A. van Nimwegen et al.
JAMA INTERNAL MEDICINE (2015)
Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
David J. Cutter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Involved-Site Image-Guided Intensity Modulated Versus 3D Conformal Radiation Therapy in Early Stage Supradiaphragmatic Hodgkin Lymphoma
Andrea Riccardo Filippi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Prospective Coronary Heart Disease Screening in Asymptomatic Hodgkin Lymphoma Patients Using Coronary Computed Tomography Angiography: Results and Risk Factor Analysis
Theodore Girinsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
A Decade of Comparative Dose Planning Studies for Early-Stage Hodgkin Lymphoma: What Can We Learn?
Maja V. Maraldo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)
Lena Specht et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Breast Cancer After Chest Radiation Therapy for Childhood Cancer
Chaya S. Moskowitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Dosimetric advantages of a butterfly technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma
Khinh Ranh Voong et al.
RADIATION ONCOLOGY (2014)
The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma
Anni Y. S. Jorgensen et al.
ACTA ONCOLOGICA (2013)
Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma
M. V. Maraldo et al.
ANNALS OF ONCOLOGY (2013)
Involved Node Radiation Therapy: An Effective Alternative in Early-Stage Hodgkin Lymphoma
Maja V. Maraldo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Second Solid Cancers After Radiation Therapy: A Systematic Review of the Epidemiologic Studies of the Radiation Dose-Response Relationship
Amy Berrington de Gonzalez et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Use of volumetric-modulated arc therapy for treatment of Hodgkin lymphoma
Young K. Lee et al.
MEDICAL DOSIMETRY (2013)
Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease
Delphine Antoni et al.
RADIATION ONCOLOGY (2013)
Changes in breast cancer risk associated with different volumes, doses, and techniques in female Hodgkin lymphoma patients treated with supra-diaphragmatic radiation therapy
Andrea Riccardo Filippi et al.
PRACTICAL RADIATION ONCOLOGY (2013)
Minimising critical organ irradiation in limited stage Hodgkin lymphoma: a dosimetric study of the benefit of involved node radiotherapy
B. A. Campbell et al.
ANNALS OF ONCOLOGY (2012)
Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults
Bilal Omer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
THYROID V30 PREDICTS RADIATION-INDUCED HYPOTHYROIDISM IN PATIENTS TREATED WITH SEQUENTIAL CHEMO-RADIOTHERAPY FOR HODGKIN'S LYMPHOMA
Laura Cella et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
DOSIMETRIC BENEFITS OF INTENSITY-MODULATED RADIOTHERAPY COMBINED WITH THE DEEP-INSPIRATION BREATH-HOLD TECHNIQUE IN PATIENTS WITH MEDIASTINAL HODGKIN'S LYMPHOMA
Amaury Paumier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Radiotherapy for Early Mediastinal Hodgkin Lymphoma According to the German Hodgkin Study Group (GHSG): The Roles of Intensity-Modulated Radiotherapy and Involved-Node Radiotherapy
Julia Koeck et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Effective Dose Reduction to Cardiac Structures Using Protons Compared With 3DCRT and IMRT in Mediastinal Hodgkin Lymphoma
Bradford S. Hoppe et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Noncoplanar intensity-modulated radiation therapy for young female patients with mediastinal lymphoma
Xinyuan Chen et al.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2012)
ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma
Ralph M. Meyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: Is it better than three dimensional conformal radiotherapy?
Vitaliana De Sanctis et al.
RADIATION ONCOLOGY (2012)
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations
Christian Fiandra et al.
RADIATION ONCOLOGY (2012)
Risk factors for radiation-induced hypothyroidism
Ivan R. Vogelius et al.
CANCER (2011)
Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non-Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) Database
Maria Werner-Wasik et al.
CLINICAL LUNG CANCER (2011)
PREDICTED RISK OF RADIATION-INDUCED CANCERS AFTER INVOLVED FIELD AND INVOLVED NODE RADIOTHERAPY WITH OR WITHOUT INTENSITY MODULATION FOR EARLY-STAGE HODGKIN LYMPHOMA IN FEMALE PATIENTS
Damien C. Weber et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Long-Term Complications of Lymphoma and Its Treatment
Andrea K. Ng et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma
Christine Herbst et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
USE OF NORMAL TISSUE COMPLICATION PROBABILITY MODELS IN THE CLINIC
Lawrence B. Marks et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
RADIATION DOSE-VOLUME EFFECTS IN THE SPINAL CORD
John P. Kirkpatrick et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Treatment of Favorable, Limited-Stage Hodgkin's Lymphoma With Chemotherapy Without Consolidation by Radiation Therapy
George P. Canellos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer
Markhaba Tukenova et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques
Laura Cella et al.
RADIATION ONCOLOGY (2010)
Risk of Second Primary Thyroid Cancer after Radiotherapy for a Childhood Cancer in a Large Cohort Study: An Update from the Childhood Cancer Survivor Study
Parveen Bhatti et al.
RADIATION RESEARCH (2010)
INVOLVED-NODE AND INVOLVED-FIELD VOLUMETRIC MODULATED ARC VS. FIXED BEAM INTENSITY-MODULATED RADIOTHERAPY FOR FEMALE PATIENTS WITH EARLY-STAGE SUPRA-DIAPHRAGMATIC HODGKIN LYMPHOMA: A COMPARATIVE PLANNING STUDY
Damien C. Weber et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
DOSIMETRIC COMPARISON OF THREE DIFFERENT INVOLVED NODAL IRRADIATION TECHNIQUES FOR STAGE II HODGKIN'S LYMPHOMA PATIENTS: CONVENTIONAL RADIOTHERAPY, INTENSITY-MODULATED RADIOTHERAPY, AND THREE-DIMENSIONAL PROTON RADIOTHERAPY
Bhishamjit S. Chera et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort
Daniel A. Mulrooney et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Cardiac morbidity following modern treatment for Hodgkin lymphoma: Supra-additive cardiotoxicity of doxorubicin and radiation therapy
Sten Myrehaug et al.
LEUKEMIA & LYMPHOMA (2008)
Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study
Andrea Gallamini et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Late cardiotoxicity after treatment for Hodgkin lymphoma
Berthe M. P. Aleman et al.
BLOOD (2007)
Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts
Carsten Nieder et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study
Anthony J. Swerdlow et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Secondary carcinogenesis in patients treated with radiation: A review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects
Herman Suit et al.
RADIATION RESEARCH (2007)
Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines
Theodore Girinsky et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
T Girinsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
M Hutchings et al.
BLOOD (2006)
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma
LB Travis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Intensity-modulated radiotherapy for lymphoma involving the mediastinum
KA Goodman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Malignant breast tumors after radiotherapy for a first cancer during childhood
C Guibout et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the late effects study group
S Bhatia et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
A Engert et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Long-term cause-specific mortality of patients treated for Hodgkin's disease
BMP Aleman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors
AK Ng et al.
BLOOD (2002)
Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger
AK Ng et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases
B Cutuli et al.
RADIOTHERAPY AND ONCOLOGY (2001)
The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: Analysis of a series of 1524 cases consecutively treated at the Florence University Hospital
E Cellai et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
FE van Leeuwen et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
